Neuroendocrine carcinoma is a rare and aggressive form of cancer that arises from neuroendocrine cells, which exhibit characteristics of both hormone-producing endocrine cells and nerve cells.  Market Overview and Growth AnalysisThe Neuroendocrine Carcinoma Market size is expected to reach US$ 4.05 Billion by 2031. The market is anticipated to register a CAGR of 8.6% during...